Collaboration to Use Big Data to Predict Malaria Outbreaks and Dengue Fever
|
By LabMedica International staff writers Posted on 22 Oct 2013 |
Scientists are collaborating to battle infectious diseases and other illnesses in real-time with better data applications for public health. The emphasis of this partnership is to help contain global outbreaks of dengue fever and malaria by applying extremely sophisticated analytic models, computing technology, and mathematical talents on an open-source framework.
Involved in the partnership are scientists from IBM (New York, NY, USA) are collaborating with Johns Hopkins University (Baltimore, MD, USA) and University of California, San Francisco (UCSF; USA). Malaria and dengue fever, which are vector-borne diseases are infections transmitted to humans and other animals by blood-feeding insects, such as mosquitoes, fleas, and ticks. Once believed to be limited geographically to the tropics or developing countries, they continue to present worldwide and are among the most complex and dangerous infectious diseases to prevent and control.
The rise of global trade, transport, and climate change allows insects to easily carry disease organisms across borders, infecting animals as well as humans. Dengue fever, for instance, has spread to over 100 countries, including the United States, and malaria is responsible for over one million per year deaths. Finding and implementing new, novel ways of predicting outbreaks is key to saving lives.
Epidemiologists rely on disease and vaccine simulations to determine the spread of global infection. Until recently, these models were hosted on closed systems and took years to produce due to ineffective data collection and lack of computing power. This approach to model development makes it too slow to respond on a timetable pertinent to unforeseen pandemics as large populations can be crippled by never before seen viruses or illnesses in a matter of days or weeks. Scientists need to better comprehend not only the dynamics of the disease itself, but also the spread of insect vectors and contributing environmental influences.
Using existing vector-borne disease models from Johns Hopkins and UCSF, IBM researchers are developing new dengue fever and malaria models that are shared as part of the open-source modeling application, spatiotemporal epidemiologic modeler (STEM). The scientists identified the prospect of integrating population analytics, algorithms of disease paths, and powerful computing to build realistic and accessible models of these infectious diseases. This tool allows for the study of disease dynamics in humans and intervention strategies such as vector control and vaccine distribution.
“Public health officials can’t afford to act on speculation during an epidemic. They need accurate and timely access to data to see what the potential spread of a disease might be for a given geographic region over a period of time,” said James Kaufman, public health manager, IBM research. “The scientific and research communities are collaborating to lead a new age of science-based, data-centric disease modeling to protect the health of people. By understanding how and why these diseases spread, we can identify those regions most susceptible to emerging disease, inform public health, and allow them to focus on specific interventions in locations where they can have the greatest impact.”
In the case of malaria, using both the model and data from the World Health Organization, IBM, and Johns Hopkins demonstrated new analytic measures for the sensitivity of malaria incidence to alterations in local climate factors such as temperature and precipitation. Determining this sensitivity makes it possible to predict where malaria incidence is most likely to increase or decrease based on predicted changes in local weather and environmental conditions in a specific region.
“There are a lot of tacit assumptions out there about how changes in climate will impact the distribution of diseases like malaria. This work suggests that things probably are not so simple, a change that has a huge effect on malaria transmission in one place might not be as important somewhere else,” said Justin Lessler, Johns Hopkins Bloomberg School of Public Health. “One of the nice things about open source projects like STEM is that now whoever wants to can download the model and start tweaking it, seeing if their own data or assumptions fundamentally change the results.”
Earlier models of dengue fever treated the mosquito vector indirectly, approximating transmission as a human-to-human contact process. IBM Research and UCSF used STEM’s ability to construct many models and integrate them with location-specific climate data. This allowed to the inclusion of the vector population into existing models, providing a more realistic description of the disease dynamics, which can present public health officials more effective predictions of epidemics spread.
“It is important to recognize the synergistic effort of theoretical and computational scientists, disease experts and public health officials making a difference in how rapidly and effectively we fight infectious diseases,” said Simone Bianco, from UC San Francisco, bioengineering and therapeutic sciences. “We have to be ready at the drop of a hat to parse through disparate data from global disease surveillance systems Anchor, conduct computationally intense research, and transfer our knowledge to public health officials to help them visualize population health, detect outbreaks, develop new models, and evaluate the effectiveness of policies.”
Available through the Eclipse Foundation, STEM is free and open to any scientist or researcher who chooses to build on and add to its library of models, computer code, and denominator data. This openness help in the development of advanced mathematical models, the generation of flexible models involving multiple species, interactions between diseases, and a better determination of epidemiology.
These achievements were published October 2013 in the journals Malaria and Theoretical Biology.
Related Links:
IBM
Johns Hopkins University
University of California, San Francisco
Involved in the partnership are scientists from IBM (New York, NY, USA) are collaborating with Johns Hopkins University (Baltimore, MD, USA) and University of California, San Francisco (UCSF; USA). Malaria and dengue fever, which are vector-borne diseases are infections transmitted to humans and other animals by blood-feeding insects, such as mosquitoes, fleas, and ticks. Once believed to be limited geographically to the tropics or developing countries, they continue to present worldwide and are among the most complex and dangerous infectious diseases to prevent and control.
The rise of global trade, transport, and climate change allows insects to easily carry disease organisms across borders, infecting animals as well as humans. Dengue fever, for instance, has spread to over 100 countries, including the United States, and malaria is responsible for over one million per year deaths. Finding and implementing new, novel ways of predicting outbreaks is key to saving lives.
Epidemiologists rely on disease and vaccine simulations to determine the spread of global infection. Until recently, these models were hosted on closed systems and took years to produce due to ineffective data collection and lack of computing power. This approach to model development makes it too slow to respond on a timetable pertinent to unforeseen pandemics as large populations can be crippled by never before seen viruses or illnesses in a matter of days or weeks. Scientists need to better comprehend not only the dynamics of the disease itself, but also the spread of insect vectors and contributing environmental influences.
Using existing vector-borne disease models from Johns Hopkins and UCSF, IBM researchers are developing new dengue fever and malaria models that are shared as part of the open-source modeling application, spatiotemporal epidemiologic modeler (STEM). The scientists identified the prospect of integrating population analytics, algorithms of disease paths, and powerful computing to build realistic and accessible models of these infectious diseases. This tool allows for the study of disease dynamics in humans and intervention strategies such as vector control and vaccine distribution.
“Public health officials can’t afford to act on speculation during an epidemic. They need accurate and timely access to data to see what the potential spread of a disease might be for a given geographic region over a period of time,” said James Kaufman, public health manager, IBM research. “The scientific and research communities are collaborating to lead a new age of science-based, data-centric disease modeling to protect the health of people. By understanding how and why these diseases spread, we can identify those regions most susceptible to emerging disease, inform public health, and allow them to focus on specific interventions in locations where they can have the greatest impact.”
In the case of malaria, using both the model and data from the World Health Organization, IBM, and Johns Hopkins demonstrated new analytic measures for the sensitivity of malaria incidence to alterations in local climate factors such as temperature and precipitation. Determining this sensitivity makes it possible to predict where malaria incidence is most likely to increase or decrease based on predicted changes in local weather and environmental conditions in a specific region.
“There are a lot of tacit assumptions out there about how changes in climate will impact the distribution of diseases like malaria. This work suggests that things probably are not so simple, a change that has a huge effect on malaria transmission in one place might not be as important somewhere else,” said Justin Lessler, Johns Hopkins Bloomberg School of Public Health. “One of the nice things about open source projects like STEM is that now whoever wants to can download the model and start tweaking it, seeing if their own data or assumptions fundamentally change the results.”
Earlier models of dengue fever treated the mosquito vector indirectly, approximating transmission as a human-to-human contact process. IBM Research and UCSF used STEM’s ability to construct many models and integrate them with location-specific climate data. This allowed to the inclusion of the vector population into existing models, providing a more realistic description of the disease dynamics, which can present public health officials more effective predictions of epidemics spread.
“It is important to recognize the synergistic effort of theoretical and computational scientists, disease experts and public health officials making a difference in how rapidly and effectively we fight infectious diseases,” said Simone Bianco, from UC San Francisco, bioengineering and therapeutic sciences. “We have to be ready at the drop of a hat to parse through disparate data from global disease surveillance systems Anchor, conduct computationally intense research, and transfer our knowledge to public health officials to help them visualize population health, detect outbreaks, develop new models, and evaluate the effectiveness of policies.”
Available through the Eclipse Foundation, STEM is free and open to any scientist or researcher who chooses to build on and add to its library of models, computer code, and denominator data. This openness help in the development of advanced mathematical models, the generation of flexible models involving multiple species, interactions between diseases, and a better determination of epidemiology.
These achievements were published October 2013 in the journals Malaria and Theoretical Biology.
Related Links:
IBM
Johns Hopkins University
University of California, San Francisco
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







